Atara Biotherapeutics, Inc. (ATRA)
Market Closed
17 Jul, 20:00
$
8. 39
-0.33
-3.7844%
$
87.94M Market Cap
- P/E Ratio
- Div Yield
81,300 Volume
-2.6 Eps
$ 8.72
Previous Close Investors:
Want to track ATRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atara Biotherapeutics (ATRA) Reports Q2 Loss, Misses Revenue Estimates
Atara Biotherapeutics (ATRA) came out with a quarterly loss of $3.10 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to loss of $17 per share a year ago.
Zacks | 1 year ago
All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy
Atara Biotherapeutics (ATRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks | 2 years ago
